← Browse by Condition
Medical Condition
chronic lymphocytic leukemia cll
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2, EARLY_Phase 1
NCT07221500 Phase 2
Recruiting
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
Enrollment
100 pts
Location
United States, Franc...
Sponsor
Nurix Therapeutics, Inc.
NCT07205315 EARLY_Phase 1
Recruiting
A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia
Enrollment
28 pts
Location
China
Sponsor
Grit Biotechnology
NCT06788639
Recruiting
A Study of Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Treated With Lisocabtagene Maraleucel in the Post-Marketing Setting
Enrollment
300 pts
Location
United States
Sponsor
Juno Therapeutics, Inc., a Bri...